Skip to content

Evaluation of the occurrence characteristics and perioperative prevention strategies of acute pancreatitis after multiple surgical procedures for the pancreas: A retrospective analysis

Evaluation of the occurrence characteristics and perioperative prevention strategies of acute pancreatitis after multiple surgical procedures for the pancreas: A retrospective analysis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600120050
Enrollment
Unknown
Registered
2026-03-09
Start date
2026-03-09
Completion date
Unknown
Last updated
2026-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-Pancreatectomy Acute Pancreatitis

Interventions

Observation group of acute pancreatitis after pancreatic surgery:None

Sponsors

Peking Union Medical College Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age >= 18 years old; 2. Performed as the main surgeon or key operator in elective pancreatic resection surgeries (including pancreaticoduodenectomy, distal pancreatic resection, pancreatic tumor enucleation) at Peking Union Medical College Hospital; 3. Possess complete perioperative and postoperative follow-up data (medical records, tests, imaging studies)

Exclusion criteria

Exclusion criteria: 1. Patients who underwent total pancreatectomy, only palliative bypass surgery, or emergency pancreaticoduodenectomy, etc.; 2. Those with moderate to severe acute pancreatitis before the operation or extensive destruction of pancreatic tissue caused by definite chronic pancreatitis; 3. Patients whose short-term prognosis was severely affected by non-pancreatic related major events during the perioperative period (such as severe trauma, terminal malignant tumors in other parts, etc.); 4. Patients with severely lacking key clinical data and unable to determine whether the main outcomes such as PPAP or death occurred. 4.Patients with substantial missing key clinical data, precluding reliable determination of PPAP occurrence or mortality and other major outcomes;

Design outcomes

Primary

MeasureTime frame
PPAP incidence;

Secondary

MeasureTime frame
Delayed gastric emptying;Postoperative bleeding;Postoperative Infection;Re-laparotomy;Postoperative serum amylase, lipase, CRP;Mortality;Postoperative pancreatic fistula;Major complication;Postoperative hyperamylasemia;

Countries

China

Contacts

Public ContactQiang Xu

Peking Union Medical College Hospital

xuqiang@pumch.cn+86 10 69152601

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 20, 2026